Best Value Stocks to Buy for February 3rd
zacks.com
Want to monitor VRCA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VRCAverrica pharmaceuticals inc. , a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the united states. the company's lead product candidate include vp-102 that is in phase iii clinical trial for the treatment of molluscum contagiosum; in phase ii clinical trial for the treatment of common warts; and completed phase i clinical trial for the treatment of genital warts.